Related Experiment Video
Updated: Feb 26, 2026

Live Imaging to Study Microtubule Dynamic Instability in Taxane-resistant Breast Cancers
Published on: February 20, 2017
Regulation of paclitaxel activity by microtubule-associated proteins in cancer chemotherapy
1Key Laboratory of Developmental Genes and Human Disease, Institute of Life Sciences, Southeast University, Nanjing, 210096, China. xingjuanshi@seu.edu.cn.
Abstract:
Microtubules, highly dynamic components of the cytoskeleton, participate in diverse cellular activities such as mitosis, cell migration, and intracellular trafficking. Dysregulation of microtubule dynamics contributes to the development of serious diseases, including cancer. The dynamic properties and functions of microtubule network are regulated by microtubule-associated proteins. Paclitaxel, an anti-microtubule agent of the taxane family, has shown a success in clinical treatment of many cancer patients. However, the variable response activity of patients and acquired resistance to paclitaxel limit the clinical use of the drug. Accumulating studies show that microtubule-associated proteins can regulate paclitaxel sensitivity in a wide range of cancer types. In this review, we will describe the roles of various microtubule-associated proteins in the regulation of paclitaxel in cancers. Particularly, we will focus on the modulation of centrosomal proteins in paclitaxel resistance. Improved understandings of how these proteins act might predict treatment responses and provide insights into more rational chemotherapeutic regimens in clinical practice.
Insights
Microtubule-associated proteins impact cancer treatment efficacy. Understanding their role, especially centrosomal proteins, can improve paclitaxel chemotherapy and overcome drug resistance.
Area of Science:
- Cell Biology
- Molecular Oncology
- Biochemistry
Background:
- Microtubules are crucial cytoskeleton components involved in cell division and migration.
- Their dynamics are regulated by microtubule-associated proteins (MAPs).
- Cancer arises from dysregulated cellular processes, including microtubule dynamics.
Purpose of the Study:
- To review the role of MAPs in regulating paclitaxel sensitivity in various cancers.
- To highlight the specific influence of centrosomal proteins on paclitaxel resistance.
- To provide insights for optimizing cancer chemotherapeutic strategies.
Main Methods:
- Literature review of studies on MAPs and paclitaxel resistance.
- Analysis of the mechanisms by which MAPs modulate microtubule dynamics.
- Focus on centrosomal proteins and their impact on drug response.
Main Results:
- MAPs significantly influence patient response to paclitaxel therapy.
- Specific MAPs can either enhance or reduce sensitivity to paclitaxel.
- Centrosomal proteins play a key role in the development of paclitaxel resistance.
Conclusions:
- MAPs are critical regulators of paclitaxel efficacy in cancer treatment.
- Targeting specific MAPs, particularly centrosomal proteins, may overcome paclitaxel resistance.
- Further understanding of MAPs can lead to personalized and more effective chemotherapy regimens.
Related Concept Videos
Drugs that Stabilize Microtubules
Drugs that Destabilize Microtubules
Destabilization of Microtubules
Microtubule Associated Proteins (MAPs)
Targeted Cancer Therapies
There are several types of targeted therapies against...
Microtubule Instability

